LONG-TERM SAFETY AND EFFICACY OF 4-WEEKLY CERTOLIZUMAB PEGOL MONOTHERAPY AND COMBINATION THERAPY IN RHEUMATOID ARTHRITIS: 5-YEAR RESULTS FROM AN OPEN-LABEL EXTENSION STUDY

被引：0

作者：

Fleischmann, R. ^{[1
]}

van Vollenhoven, R. ^{[2
]}

Vencovsky, J. ^{[3
]}

Alten, R. ^{[4
]}

Davies, O. ^{[5
]}

Stach, C. ^{[6
]}

de Longueville, M. ^{[5
]}

VanLunen, B. ^{[7
]}

Choy, E. ^{[8
]}

机构：

[1] Univ Texas SW Med Ctr Dallas, Metroplex Clin Res Ctr, Dallas, TX 75390 USA

[2] Karolinska Inst, Stockholm, Sweden

[3] Inst Rheumatol, Prague, Czech Republic

[4] Charite, Schlosspk Klin, D-13353 Berlin, Germany

[5] UCB Pharma, Brussels, Belgium

[6] UCB Pharma, Monheim, Germany

[7] UCB Pharma, Raleigh, NC USA

[8] Cardiff Univ, Sch Med, Cardiff CF10 3AX, S Glam, Wales

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 72卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：435 / 435

页数：1

共 50 条

[1] Long-Term Safety and Efficacy of 4-Weekly Certolizumab Pegol Combination and Monotherapy in Rheumatoid Arthritis: 5 Year Results from an Open Label Extension Study
Fleischmann, Roy M.
van Vollenhoven, Ronald F.
Vencovsky, Jiri
Alten, Rieke
Davies, Owen
Stach, Christian
de Longueville, Marc
Van Lunen, Brenda
Choy, Ernest
[J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S565 - S566
[2] LONG-TERM SAFETY OF 4-WEEKLY CERTOLIZUMAB PEGOL IN RHEUMATOID ARTHRITIS: 5 YEAR RESULTS FROM AN OPEN LABEL EXTENSION STUDY
Fleischmann, R.
van Vollenhoven, R.
Vencovsky, J.
Alten, R.
Davies, O.
Stach, C.
de Longueville, M.
van Lunen, B.
Choy, E.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 523 - 523
[3] LONG-TERM BENEFITS OF 4-WEEKLY CERTOLIZUMAB PEGOL MONOTHERAPY AND COMBINATION THERAPY ON HOUSEHOLD PRODUCTIVITY AND SOCIAL PARTICIPATION IN RHEUMATOID ARTHRITIS: 5-YEAR RESULTS FROM AN OPEN-LABEL EXTENSION STUDY
Strand, V.
Purcaru, O.
van Vollenhoven, R.
Choy, E.
Fleischmann, R.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 441 - 442
[4] LONG-TERM BENEFITS OF 4-WEEKLY CERTOLIZUMAB PEGOL COMBINATION AND MONOTHERAPY ON HOUSEHOLD PRODUCTIVITY AND SOCIAL PARTICIPATION IN RHEUMATOID ARTHRITIS: 5 YEAR RESULTS FROM AN OPEN LABEL EXTENSION STUDY
Strand, V
Purcaru, O.
Van Vollenhoven, R.
Choy, E.
Fleischmann, R.
[J]. VALUE IN HEALTH, 2012, 15 (07) : A451 - A452
[5] Long-Term Benefits of 4-Weekly Certolizumab Pegol Combination and Monotherapy On Household Productivity and Social Participation in Rheumatoid Arthritis: 5 Year Results from an Open Label Extension Study
Strand, Vibeke
Purcaru, Oana
van Vollenhoven, Ronald F.
Choy, Ernest
Fleischmann, Roy
[J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S567 - S567
[6] 5-YEAR RESULTS FROM THE RAPID 1 TRIAL AND OPEN-LABEL EXTENSION: LONG-TERM SAFETY AND EFFICACY OF CERTOLIZUMAB PEGOL IN COMBINATION WITH METHOTREXATE IN THE TREATMENT OF RHEUMATOID ARTHRITIS
Keystone, E.
Landewe, R.
van Vollenhoven, R.
Combe, B.
Strand, V.
Mease, P. J.
Shaughnessy, L.
VanLunen, B.
van der Heijde, D.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 228 - 229
[7] Long-term safety and efficacy of certolizumab pegol in combination with methotrexate in the treatment of rheumatoid arthritis: 5-year results from the RAPID 1 trial and open-label extension
Keystone, Edward
Landewe, Robert
van Vollenhoven, Ronald
Combe, Bernard
Strand, Vibeke
Mease, Philip
Shaughnessy, Laura
VanLunen, Brenda
van der Heijde, Desiree
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (12) : 2094 - 2100
[8] Long-Term Safety and Efficacy Of Certolizumab Pegol In Combination With Methotrexate In The Treatment Of Rheumatoid Arthritis: 5-Year Results From a 24-Week Randomized Controlled Trial and Open-Label Extension Study
Smolen, Josef S.
van Vollenhoven, Ronald
Kavanaugh, Arthur
Strand, Vibeke
Vencovsky, Jiri
Schiff, Michael H.
Landewe, Robert
Haraoui, Boulos
Walker, Susan
van der Heijde, Desiree
[J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S988 - S989
[9] Long-Term Safety and Efficacy Of Certolizumab Pegol In Combination With Methotrexate In The Treatment Of Rheumatoid Arthritis: 5-Year Results From a 52-Week Randomized Controlled Trial and Open-Label Extension Study
Keystone, Edward
Landewe, Robert
van Vollenhoven, Ronald
Combe, Bernard
Strand, Vibeke
Mease, Philip J.
Shaughnessy, Laura
VanLunen, Brenda
van der Heijde, Desiree
[J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S596 - S597
[10] LONG-TERM SAFETY AND EFFICACY OF CERTOLIZUMAB PEGOL IN COMBINATION WITH METHOTREXATE IN THE TREATMENT OF RHEUMATOID ARTHRITIS: 5-YEAR RESULTS FROM A 52-WEEK RANDOMIZED CONTROLLED TRIAL AND OPEN-LABEL EXTENSION STUDY
Keystone, Edward
Landewe, Robert
van Vollenhoven, Ronald
Combe, Bernard
Strand, Vibeke
Mease, Philip J.
Shaughnessy, Laura
vanlunen, Brenda
van der Heijde, Desiree
[J]. RHEUMATOLOGY, 2014, 53 : 96 - 96

← 1 2 3 4 5 →